Tehran: Iranian researchers have successfully developed the latest version of the cancer medication Tederox, which is designed to help patients live longer. This breakthrough was achieved by a pharmaceutical knowledge-based company and was recently showcased at the Iran Nano 2024 Exhibition, held in Tehran from November 3 to 6. According to Islamic Republic News Agency, Ali Aghajani, a pharmacist and the business development manager at the company, explained that the newly-developed version of Tederox offers targeted treatment. This advancement not only extends the lifespans of cancer patients but also minimizes the common side effects associated with cancer medications. The development process for this innovative drug took four years to complete.